IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Waldenström Macroglobulinemia
Memorial Sloan Kettering Cancer Centermonoclonal_antibodyPhase 3Active
BB
70/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 89/ 100
Competitive context
59 Active assets in the Waldenström Macroglobulinemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Fred Hutchinson Cancer Center | Phase 2 | BBB |
Cyclophosphamide Institute of Hematology & Blood Diseases Hospital, China | Phase 2 | BBB |
Fludarabine Institute of Hematology & Blood Diseases Hospital, China | Phase 3 | BBB |
PREDNISONE TABLETS BeOne Medicines | Phase 2 | BBB |
Inno-206 BeOne Medicines | Phase 2 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →